Decreased levels of the target enzyme thymidylate synthase (TS) have been repeatedly associated with superior clinical outcome in gastrointestinal cancers, including stomach cancer (Leichman et al, 1995; Boku et al, 1998; Shirota et al, 2001). Here, TYMS is linked to gastric cancer.